H1 2026: Finalize formulation and manufacture test product. H1 2026 Initial Phase 1 pharmacokinetic clinical cross-over study. "Our pipeline is focused on research in therapeutic areas where we can ...
VANCOUVER,BC / ACCESS Newswire / September 29, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery ...
ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, ...
Regulatory submission to expand the label for Igalmi use in the outpatient setting is expected in the first quarter of 2026. At-home administration of dexmedetomidine sublingual film as a treatment ...
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...
The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...
The era of compounded HCG is officially over. One of the nation's leading suppliers of FDA-approved commercial HCG, NuCare Pharmaceuticals, shares what clinics and pharmacies need to know now. ORANGE, ...
Bengaluru: The Central Drugs Standards Control Organisation (CDCSO) has set up a team to inspect the ethics committee of HCG Hospital, Bengaluru, amid concerns over conduct of clinical trials at the ...
BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an investigation into alleged unethical clinical trials at Bengaluru-based HCG ...
Bengaluru: Amid allegations of unethical clinical trial practices, HealthCare Global Enterprises Limited (HCG), a leading cancer care provider in India, has denied any wrongdoing and reaffirmed its ...
In a shocking scenario, the Karnataka government has written to the Drug Controller General of India demanding an investigation into the alleged unfair clinical trials. The Karnataka government claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback